logo-loader

Cannvas MedTech raises C$1 million after closing on first tranche of private placement

Last updated: 09:10 16 Jul 2019 EDT, First published: 08:53 16 Jul 2019 EDT

cannabis
Cannvas said it intends to use the proceeds for developing the technology platforms and general working capital

Cannvas MedTech Inc (CSE: MTEC) (OTCPK:CANVF) announced Tuesday it has raised slightly more than C$1 million after closing on the first tranche of a non‑brokered private placement.

The Toronto-based cannabis education and analytics company issued a total of 5,007,500 units at a price of C$0.20 per unit. 

Each unit consists of one common share and one transferable common share purchase warrant exercisable at C$0.30 per share for a period of two years.

READ: Cannvas MedTech says planned expansion into Europe is on track; plans to raise C$2M

Cannvas said it intends to use the proceeds for developing the technology platforms and general working capital.

The company anticipates closing the second and final tranche of the financing in short order.

Insiders of Cannvas subscribed for 275,000 units, including CEO Shawn Moniz, CEO (125,000 units), COO Steve Loutskou (125,000 units) and Lindsay Hamelin, a director of the company (25,000 units).

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Buds & Duds: Cannabis stocks reverse; Nabis Holdings jumps after securing...

The North American Marijuana Index, lost 1.5% to 136 points. The OTCQX Cannabis Index dipped 1.4% to 504 points. Buds today were Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), EuroLife Brands Inc (CSE:EURO) (OTCMKTS:CANVF). Duds were HEXO Corp (TSE:HEXO) (NYSE:HEXO), Aphria Inc (TSE:APHA)...

on 10/16/2019